Novo Nordisk A/S Common Stock (NY:NVO)
Price and Volume
Detailed Quote| Volume | 13,204,024 |
| Open | 40.98 |
| Bid (Size) | 40.64 (300) |
| Ask (Size) | 40.65 (300) |
| Prev. Close | 40.93 |
| Today's Range | 40.43 - 41.28 |
| 52wk Range | 35.12 - 81.44 |
| Shares Outstanding | N/A |
| Dividend Yield | 2.88% |
Top News
More News
3 Ways to Invest in the Growing GLP-1 Weight Loss Market ↗
April 17, 2026
Via MarketBeat
Performance
| YTD |
-22.7%
|
-22.7%
|
| 1 Month |
+9.3%
|
+9.3%
|
| 3 Month |
-33.2%
|
-33.2%
|
| 6 Month |
-27.3%
|
-27.3%
|
| 1 Year |
-30.5%
|
-30.5%
|
More News
Read More
Could AbbVie Crash Lilly's Weight‑Loss Party? ↗
April 14, 2026
Via The Motley Fool
Via MarketMinute
3 Absurdly Cheap Dividend Stocks to Buy in April 2026 ↗
April 08, 2026
Via The Motley Fool
Topics
Economy
Via MarketBeat
Via MarketMinute
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
April 02, 2026
Via MarketMinute
Topics
Economy
Why Eli Lilly Stock Trounced the Market Today ↗
April 01, 2026
Via The Motley Fool
Via The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 40.52
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 04/17/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>